Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

TREACE MEDICAL CONCEPTS, INC.

(TMCI)
  Report
Delayed Nasdaq  -  04:00:00 2023-03-30 pm EDT
25.72 USD   +0.67%
03/12Insider Sell: Treace Medical Concepts
MT
03/10Treace Medical Concepts, Inc. : Other Events (form 8-K)
AQ
03/08Treace Medical Concepts Shares Rise After Q4 Loss Narrows, Revenue Increases
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Treace Medical Concepts, Fusion Orthopedics Agree to Settle Patent Dispute

03/03/2023 | 09:42am EDT


© MT Newswires 2023
All news about TREACE MEDICAL CONCEPTS, INC.
03/12Insider Sell: Treace Medical Concepts
MT
03/10Treace Medical Concepts, Inc. : Other Events (form 8-K)
AQ
03/08Treace Medical Concepts Shares Rise After Q4 Loss Narrows, Revenue Increases
MT
03/08Morgan Stanley Adjusts Price Target on Treace Medical Concepts to $30 From $28, Maintai..
MT
03/08Sector Update: Health Care Stocks Flat to Lower Pre-Bell Wednesday
MT
03/08TREACE MEDICAL CONCEPTS, INC. Management's Discussion and Analysis of Financial Condit..
AQ
03/08Treace Medical Concepts Narrows Q4 Net Loss, Revenue Increases
MT
03/07Treace Medical Concepts Narrows Q4 Net Loss, Revenue Increases
MT
03/07Treace Medical Concepts, Inc. Provides Revenue Guidance for the Full Year 2023
CI
03/07Transcript : Treace Medical Concepts, Inc., Q4 2022 Earnings Call, Mar 07, 20..
CI
More news
Analyst Recommendations on TREACE MEDICAL CONCEPTS, INC.
More recommendations
Financials (USD)
Sales 2023 191 M - -
Net income 2023 -45,5 M - -
Net cash 2023 89,7 M - -
P/E ratio 2023 -33,7x
Yield 2023 -
Capitalization 1 573 M 1 573 M -
EV / Sales 2023 7,78x
EV / Sales 2024 6,51x
Nbr of Employees 423
Free-Float 54,9%
Chart TREACE MEDICAL CONCEPTS, INC.
Duration : Period :
Treace Medical Concepts, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TREACE MEDICAL CONCEPTS, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 25,72 $
Average target price 29,75 $
Spread / Average Target 15,7%
EPS Revisions
Managers and Directors
John T. Treace Chief Executive Officer & Director
Mark L. Hair Chief Financial Officer
James T. Treace Chairman
Shana R. Zink Senior VP-Clinical Affairs
Terry Lubben Senior Vice President-Operations
Sector and Competitors
1st jan.Capi. (M$)
TREACE MEDICAL CONCEPTS, INC.11.87%1 573
PENUMBRA, INC.24.56%10 579
MASIMO CORPORATION19.16%9 392
SHOCKWAVE MEDICAL, INC.4.16%7 816
GETINGE AB15.72%6 577
NOVOCURE LIMITED-20.60%6 142
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
fermer